2000•GastroenterologyOpen access

Budesonide is superior to mesalazine in maintaining disease remission for patients with steroiddependent Crohn's disease

Gerassimos J. Mantzaris, Kalliopi Petraki, Emmanuel Archavlis, Helen Chadio-Iordanidou, Angela Christidou, Christos Zografos, Efterpi Chiotakakou, George Triantafyllou

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Mesalazine, Budesonide, Crohn's disease, Medicine, Gastroenterology, Internal medicine, Disease, Inflammatory bowel disease

Back to paper search Browse research topics Original source

Budesonide is superior to mesalazine in maintaining disease remission for patients with steroiddependent Crohn's disease — Research Paper | ScholarLens